Home › Companies › Kezar Life Sciences Inc.

Kezar Life Sciences Inc. proxy voting records

How asset managers voted at Kezar Life Sciences Inc.’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.

• CUSIP issuer number49372L
• SEC CIK1645666

Recent shareholder votes

• June 18, 2024 annual meeting (2023-2024 proxy season): 5 items in Kezar Life Sciences Inc.'s official results (Form 8-K, filed June 21, 2024); lowest support 42% of votes cast (The compensation paid to the Company's named executive officers…); The compensation paid to the Company's named executive officers… did not pass (42%). Full results and how funds voted.

Each line is the company’s own Form 8-K tally as shown on that season’s page; support is FOR as a share of votes cast.

Proxy seasons

Earlier seasons list this company under the name KEZAR LIFE SCIENCES INC., as its holders filed it.

Explore Kezar Life Sciences Inc. in the interactive database

The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. This page is rebuilt weekly; built November 9, 2026.